331 related articles for article (PubMed ID: 16514175)
1. Lixazinone stimulates mitogenesis of Madin-Darby canine kidney cells.
Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Zhou W; Grande JP
Exp Biol Med (Maywood); 2006 Mar; 231(3):288-95. PubMed ID: 16514175
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4.
Cheng J; Thompson MA; Walker HJ; Gray CE; Diaz Encarnacion MM; Warner GM; Grande JP
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F940-53. PubMed ID: 15280158
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid.
Matousovic K; Tsuboi Y; Walker H; Grande JP; Dousa TP
J Lab Clin Med; 1997 Nov; 130(5):487-95. PubMed ID: 9390636
[TBL] [Abstract][Full Text] [Related]
4. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis.
Chini CC; Grande JP; Chini EN; Dousa TP
J Biol Chem; 1997 Apr; 272(15):9854-9. PubMed ID: 9092521
[TBL] [Abstract][Full Text] [Related]
5. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
Cheng J; Grande JP
Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors: role of protein kinase A in vascular smooth muscle cell mitogenesis.
Osinski MT; Schrör K
Biochem Pharmacol; 2000 Aug; 60(3):381-7. PubMed ID: 10856433
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
8. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M
Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
[TBL] [Abstract][Full Text] [Related]
9. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
11. Role of PDE4 in superoxide anion generation through p44/42MAPK regulation: a cAMP and a PKA-independent mechanism.
Jacob C; Szilagyi C; Allen JM; Bertrand C; Lagente V
Br J Pharmacol; 2004 Sep; 143(2):257-68. PubMed ID: 15313882
[TBL] [Abstract][Full Text] [Related]
12. Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors.
Liu S; Veilleux A; Zhang L; Young A; Kwok E; Laliberté F; Chung C; Tota MR; Dubé D; Friesen RW; Huang Z
J Pharmacol Exp Ther; 2005 Aug; 314(2):846-54. PubMed ID: 15901792
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
[TBL] [Abstract][Full Text] [Related]
14. Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase.
McEwan DG; Brunton VG; Baillie GS; Leslie NR; Houslay MD; Frame MC
Cancer Res; 2007 Jun; 67(11):5248-57. PubMed ID: 17545604
[TBL] [Abstract][Full Text] [Related]
15. Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.
Tsuboi Y; Shankland SJ; Grande JP; Walker HJ; Johnson RJ; Dousa TP
J Clin Invest; 1996 Jul; 98(2):262-70. PubMed ID: 8755633
[TBL] [Abstract][Full Text] [Related]
16. The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21(Cip1) and p27(Kip1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells.
Chen TC; Wadsten P; Su S; Rawlinson N; Hofman FM; Hill CK; Schönthal AH
Cancer Biol Ther; 2002; 1(3):268-76. PubMed ID: 12432276
[TBL] [Abstract][Full Text] [Related]
17. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
Tilley DG; Maurice DH
Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21(WAF1/CIP1) proteins in human acute lymphoblastic leukemia cells.
Ogawa R; Streiff MB; Bugayenko A; Kato GJ
Blood; 2002 May; 99(9):3390-7. PubMed ID: 11964308
[TBL] [Abstract][Full Text] [Related]
19. Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes.
Ekholm D; Mulloy JC; Gao G; Degerman E; Franchini G; Manganiello VC
Biochem Pharmacol; 1999 Sep; 58(6):935-50. PubMed ID: 10509746
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.
Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML
Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
